British American Tobacco $BATS (-2,66 %) has specified its annual targets for 2025.

The cigarette company announced in London today that sales are set to increase by two percent in constant currencies in the current year.

The Group is therefore still aiming for growth at the upper end of the one to two percent forecast recently.

Adjusted operating profit is also expected to grow by two percent in constant currencies.

Previously, the management had planned an increase of 1.5 to 2.5 percent.

In addition, BAT increased its share buyback program for 2026 to 1.3 billion British pounds (just under 1.5 billion euros) 👍🏻

"The annual targets are still on track," said CEO Tadeu Marroco according to the statement.

The positive development in the USA, the world's largest market for nicotine products, is particularly pleasing.

Sales volumes and turnover of the disposable e-cigarette Vuse have also improved overseas, although Vapour products continue to be affected by illegal distribution.

Revenue from the Group's new category accelerated to double-digit percentage growth in the second half of the year.

BAT has long been focusing on expanding its business with alternatives to traditional cigarettes. These include e-cigarettes, tobacco heaters and tobacco-free nicotine pouches.

Meanwhile, the management is confident about its medium-term goals. Accordingly, turnover is expected to increase by three to five percent and adjusted earnings per share by five to eight percent from next year. In 2026, however, only the lower end of the forecast ranges is likely to be achieved, it said

While I wandered through Rostock and Schwerin, spent a frugal night and found a moment of peace in Schwerin Cathedral, my depots simply carried on doing their thing. No hectic rush, no manual interventions, no nervous glances at my smartphone. The automation of my reinvestments, savings plans and standing orders is simply worth its weight in gold!

And then, right in that moment of silence in the cathedral, a message demanded my attention. It was the moment when the biggest dividend of the month arrived. A sign from the very top, or timing straight out of a picture book? Back home at the end of the month, a new player became apparent in the portfolio, which advanced into the top 5. But catching up with my strongest stock is still a long way off for the new challenger. Time for a review.

Overall performance

For me, November in general was the same as always: steady and boring. I didn't even really notice that the US budget shutdown had ended. Just as well, because business as usual can continue.

My key performance indicators for my overall portfolio at a glance:

• TTWROR (month under review): +1.40 % (previous month: +1.39 %)
• TTWROR (since inception): +79,75 %
• IZF (month under review): +18.54 % (previous month: +9.65 %)
• IZF (since inception): +11,22 %
• Delta: +1,211.47 €
• Absolute change: +€2,398.46

Performance & volume

$AVGO (-14,32 %) remains the heavyweight in the portfolio, but as mentioned in the introduction, there is a new challenger that made significant gains in November and has now moved into the top 5. $GOOGL (-3,46 %) pulls past $BAC (+1,27 %) . They have just delivered. New Gemini and Nano Banana version. The constant new advances in AI are the clear driver here. But watch out! The question in the future will be who will earn money with AI. Will it be those who have integrated it into their products or those who create the basic prerequisites for its use via data centers and hardware? I am curious.

And even if this competition is super exciting, these values are not in my sights, more on that later in the outlook.

Size of individual stock positions by volume in the overall portfolio:

Share ( %) of total portfolio (and associated portfolio):

$AVGO (-14,32 %) 3.57 % (main share portfolio)

$WMT (+2,51 %) 1.75 % (main share portfolio)

$GOOGL (-3,46 %) 1.56 % (main share portfolio)

$NFLX (+0,45 %) 1.60 % (main share portfolio)

$BAC (+1,27 %) 1.46 % (main share portfolio)

Smallest individual share positions by volume in the overall portfolio:

Share ( %) of the total portfolio (and associated securities account):

$NOVO B (-0,2 %) : 0.45 % (main share portfolio)

$GIS (+1,15 %) : 0.56 % (crypto follow-on portfolio)

$BATS (-2,66 %) 0.57 % (main share portfolio)

$TGT (+2,16 %) 0.57 % (main share portfolio)

$MDLZ (+0,94 %) 0.59 % (main share portfolio)

Top-performing individual stocks

Shares with performance since initial purchase ( %) (and the respective portfolio):

$AVGO (-14,32 %) : +369 % (main share portfolio)

$NFLX (+0,45 %) +120 % (main share portfolio)

$GOOGL (-3,46 %) +119 % (main share portfolio)

$WMT (+2,51 %) +95 % (main share portfolio)

$OHI (+0,64 %) + 90 % (main share portfolio)

Flop performer individual stocks

Shares with performance since initial purchase ( %) (and the respective portfolio):

$TGT (+2,16 %) : -35 % (main share portfolio)

$GIS (+1,15 %) : -35 % (main share portfolio)

$NKE (-0,55 %) -31 % (main share portfolio)

$NOVO B (-0,2 %) -29 % (main share portfolio)

$CPB (-0,33 %) -26 % (main share portfolio)

Asset allocation

Equities and ETFs currently determine my asset allocation.

ETFs: 41.3 %

Equities: 58.6 %

Crypto: 0.0 %

P2P: less than 0.01 %

Investments and subsequent purchases

I have invested the following amounts in savings plans:

Planned savings plan amount from the fixed net salary: € 1,030

Planned savings plan amount from the fixed net salary, incl. reinvested dividends according to plan size: € 1,140

Savings ratio of the savings plans to the fixed net salary: 49.75

In addition, the following additional investments were made from returns, refunds, cashback, etc. as one-off savings plans/repurchases:

Subsequent purchases/one-off savings plans as cashback annuities from refunds: € 75.00

Subsequent purchases/one-off savings plans as a cashback annuity from bonuses: € 21.98

Subsequent purchases from other surpluses: € 0.00* (additional purchases are only made in December)

Automatically reinvested dividends by the broker: € 2.08 (function is only activated for an old custody account, as I otherwise prefer to control the reinvestment myself)

Unscheduled purchases were made on various securities accounts outside the regular savings plans:

Number of unscheduled purchases: 9

21.98 € for $SPYW (-0,07 %)

35.00 € for $SPYW (-0,07 %)

40.00 € for $GGRP (-0,6 %)

35.00 € for $GGRP (-0,6 %)

Passive income from dividends

I received € 113.15 in dividends (€ 82.45 in the same month last year). This corresponds to a change of +37.36 % compared to the same month last year. For a rather weak month, this is a great sum, which I am grateful for and from which I made a small donation in addition to reinvesting, as I did in September and October. Other key figures:

Number of dividend payments: 22

Number of payment days: 10 days

Average dividend per payment: € 5.60

average dividend per payday: € 12.32

The top three payers in the month under review were:

$IWDP (-0,83 %)

$ZPRG (-0,18 %)

$HTGC (-0,31 %)

My passive income from dividends (and some interest) mathematically covered 12.59% of my expenses for the month under review. Acceptable for a weak month with medium-high expenses (by my standards).

Crypto performance

As I play by the cycle theory, I got out of crypto completely in October. The share was previously insignificant in my portfolio anyway, but the harvest has nevertheless been reaped. Only the Oracle of Delphi knows whether I am right with my approach. There was more in an earlier getquin post from me, in which I explained my assumptions and strategy in detail.

So there are no key figures to report. Now it's time to learn and understand.

Performance comparison: portfolio vs. benchmarks

A comparison of my portfolio with two important ETFs shows the TTWROR in the current month (and since the beginning):

My portfolio: +1.40 % (since I started: +79.75 %)

$VWRL (-0,98 %) -0.50 % (since my start: 62.52 %)

$VUSA (-1,22 %) -0.48 % (since my start: 58.04 %)

Finally performed better than my chosen benchmark ETFs.☺️

Risk figures

Here are my risk figures for the month under review:

Maximum drawdown: YTD: 17.17% (month under review: 2.34%)

Maximum drawdown duration: 702 days since inception (reporting month: 14 days)

Volatility: YTD: 28.15 % (in the month under review: 2.44 %)

Sharpe Ratio: YTD: 0.39 (in the month under review: 7.63)

Semi-volatility: YTD: 20.91 % (in the month under review: 1.75 %)

The maximum drawdown of 702 days since the beginning is a long period 2022-2023 before the year-end rally began at the end of 2023. Otherwise the figures suit me well.

My Sharpe ratio of 0.39 YTD shows that I have achieved a return of 0.39 units above the risk-free rate per unit of risk.

My vola of 28.15% YTD is the direct footprint of the loud roar and then small cave-in of Trump's tariff policy. It has proven itself again: For me as a long-term investor, what counts is simply staying calm and buying the dip when another dip comes.

Outlook

I still have some money left over from my food and drugstore budget, but I won't be (re)investing it until December with the surpluses I hope to have by then. I've chosen a boring REIT that won't be $O, but still pays out monthly dividends and has long been a position in my portfolio. Strictly speaking, I've seen little or no mention of this stock among the financial tycoons recently. You'll see which one in the next review.

The last point will be a little more personal again. Loyal readers of my reviews will know from the August review that this summer I was diagnosed with aortic ectasia of the ascending aorta near the heart as a result of the bicuspid and insufficient aortic valve. An incidental finding that will be treated with the necessary seriousness through close monitoring and an upcoming operation. And precisely because of this, it is no longer the ticking time bomb that it would be if it were still undetected and possibly larger. The knowledge of this and now my own adjustment to day X is gradually changing my way of thinking. Before the discovery, when I was just a patient with a leaky aortic valve who regained a lot after changing my lifestyle for the better, e.g. exercise, I was influenced by the idea that I had a lot of time to implement what was on my mind. Now I know that I want to get a few things done before the day of the procedure and the lengthy recovery. I am now aware of the issue of time in a whole new way. Why am I writing this publicly? Because I want to show that finances are certainly important, but only one piece of the puzzle of life.

So, that's enough writing. With that in mind, have a wonderful Christmas.

Thank you for reading. Stay healthy and happy!

👉 You can also see my review on Instagram from next week (portfolio review from 8.12.25 and budget review from 9.12.25).

📲 In addition to the portfolio and budget review, there are currently three posts a week: @frugalfreisein

!!! Please pay close attention to the spelling of my alias. Unfortunately, there are too many fake and phishing accounts on social media. I have already been "copied" several times.

👉 How was your month at the depot? Do you have any tops and flops to report? Leave your thoughts in the comments!

The sensible use of saved capital in retirement requires good planning. Especially if you want money to flow out of it regularly to secure or sweeten the third stage of your life.

Financial brokers then like to offer pension insurance based on a single payment, often called an immediate annuity.

With a normal life expectancy, the return is usually not generous because insurers usually invest very conservatively. In addition, the costs and profit margins of the insurance company further reduce the return. Consumer advocates point out that you usually have to live to be 94 years or older before you receive the investment sum back via guaranteed pensions.

It is often more profitable to park the money in a call money account.

Investments with regular distributions are an alternative. Investors are spoiled for choice between several thousand dividend-paying equity funds.

What are the relevant selection criteria? Quality and cost structure.

For some, the level of distributions may also be an important criterion in the selection process. But caution is advised here: For example, the payout ratio of the Global X Super Dividend ETF $SDIP (-0,2 %) is currently over nine percent. With an investment sum of 100,000 euros, this results in a monthly inflow of around 750 euros before tax.

This is possible because the ETF invests stubbornly in the 100 companies with the highest dividends worldwide, but without any consideration of the sustainability of these distributions and the quality of the companies.

This in turn means that, without the dividends, the ETF generated a return of zero over one year and even minus 14% over three years. Investors therefore received high regular payouts, but the investment capital decreased significantly at the same time.

Savers should therefore always pay attention to how the ETF invests. There are various positive counter-examples, such as the Invesco Euro Stoxx High Dividend Low Volatility ETF $EUHD (-0,55 %). Although this also focuses on high-dividend companies, it also selects according to qualitative criteria. Result: Although the payout ratio is currently "only" 5.1% per year, this amounts to around EUR 425 per month before tax for an investment sum of EUR 100,000.

However, the ETF has also achieved growth of almost 36% over the past three years, and including distributions, the gain was even over 60%. There are similarly good ETFs for various other investment regions or sectors.

Bond ETFs, on the other hand, are rarely a real alternative for private investors. Although distribution rates of four or five percent can be achieved, this is ultimately only possible with high-risk bonds or US securities with a corresponding currency risk. In addition, a positive return can rarely be achieved over and above the distribution.

A (possibly riskier) alternative is to invest in individual shares with high dividends. However, quality is even more important here. "We value companies with a strong balance sheet that are characterized by a high equity ratio and above-average returns on capital and sales," says Franz Kaim from Kidron Vermögensverwaltung in Stuttgart.

Continuity is also important. "The so-called dividend aristocrats are the gold standard for income-oriented investors," says Rainer Laborenz, Managing Partner of Azemos Vermögensverwaltung in Offenburg. "Companies that have increased their dividends for at least 25 consecutive years are included in this select group."

There are currently around 150 dividend aristocrats worldwide, 117 of which are from the USA and 33 from the rest of the world. The best-known names include Coca-Cola $KO (+1,67 %)Procter & Gamble $PG (+1,17 %) and Johnson & Johnson $JNJ (+1,28 %) from the USA, Fresenius from Germany $FRE (-0,97 %) and Unilever $ULVR (-0,71 %) from Great Britain.

Other attractive dividend stocks recommended in a WELT survey of ten leading asset managers in Germany include Allianz $ALV (-0,79 %)BASF $BAS (+0,71 %)Beiersdorf $BEI (-0,65 %)Deutsche Post $DHL (+0,05 %) and Munich Re $MUV2 (+0,12 %).

In other European countries, they rely on BAT $BATS (-2,66 %), BP $BP. (-1,12 %), Nestlé $NESN (-0,7 %), NN Group $NN (-0,64 %)Shell $SHEL (-1 %) and Swiss Life $SLHN (+0,14 %).

In the USA, names such as Altria $MO (-0,39 %), Chevron $CVX (-1,24 %)Cisco $CSCO (-2,24 %), Coca-Cola, Kimberly-Clark $KMB (-0,51 %) , McDonald's $MCD (+1,12 %) or Pepsi $PEP (+0,29 %).

Source: Text (excerpt) & table: Welt, 05.12.25

British American Tobacco $BATS (-2,66 %) has completed the sale of 187,500,000 ordinary shares in ITC Hotels Limited, representing 9% of the company's issued share capital, the tobacco group has announced.

The block trade, which was conducted through an accelerated bookbuilding process, raised net proceeds of INR 38.2 billion (equivalent to approximately £315 million at current exchange rates). Following the transaction, BAT continues to hold a 6.3% stake in ITC Hotels.

According to the company's announcement, the proceeds will be used to advance BAT's goal of achieving a debt corridor of 2 to 2.5 times adjusted net debt to adjusted EBITDA (adjusted for Canada) by the end of 2026.

The transaction follows an initial announcement by BAT on Thursday regarding the planned block trade.

The company did not disclose the investors who acquired the shares.

BAT employs more than 48,000 people worldwide and reported sales of £25.9 billion and adjusted operating profit of £11.9 billion for 2024. The company has set itself the goal of attracting 50 million adult consumers to its smoke-free products by 2030 and generating 50% of its revenue from them by 2035.

The securities traded in this transaction have not been registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements, according to the press release.

Ho ho ho you beautiful Christmas time...

...here again the monthly look in the rear-view mirror🔎

The first thing that surprises me is the fact that the Getquin Rewind is more positive than my monthly benchmark at the end of the month 🤔

According to Rewind, I ended the month with + 1.07%...

...whereas my benchmark closed the month at -0.46% as at 30.11.2025 🤷🏻‍♂️

I can't quite put this together yet, but I assume that the cut-off date for the calculation was different from 30.11. or that gross dividends are also used in some cases 🤷🏻‍♂️

Be that as it may, for me the benchmark is the measure of all things in this context and the month ended with -0.46% 📉

A year-end rally also looks different to me, but all in all I'm quite satisfied with the annual results so far and am close to the lower range of my targets, which have been raised twice so far...

...over the year as a whole, I'm also quite satisfied so far and am on a par with or a nose ahead of the Nasdaq, although my portfolio is anything but tech/growth-heavy 😅

If things continue like this, I see myself well on the way to the first 100k 💪🏻

And if things go really well, this goal could even be reached during the term of office of the Orang(e)-Uta 🍊.

But as we all know, things often turn out differently than you think, so keep spitting in your hands and looking ahead...

In terms of dividends, the month also looked a little better again:

》Gross: € 217.01

》Net: € 176.09

》Yield (TTM): 6.033%

》YOC (TTM): 6.928%

These two values would actually be a little higher, but with every further purchase without a dividend received, they naturally fall again slightly 😉

》Total net dividend: € 1479.94

》CAGR: 495.30%

All in all, after 2 1/2 years, I think it's still easy to bear and should continue to rise steadily in the future, or rather, "the squirrel feeds on hard work" 🙂

》My top 3 this month:

🟢 $BATS (-2,66 %) +14,16% (+100,07%)

🟢 $DTE (-0,8 %) +1,35% (-1,57%)

🟢 $WINC (-0,81 %) +1,30% (+5,31%)

》My flop 3 this month:

🔴 $3750 (+0,54 %) -16,35% (+47,92%)

🔴 $YYYY (-0,98 %) -7,34% (+3,70%)

🔴 $VAR (-0,28 %) -5,49% (+1,01%)

》Disposals:

none

》Additions:

none

》Increased:

$DTE (-0,8 %)

$VAR (-0,28 %)

$1211 (-1,03 %)

Apart from that, there wasn't really much else new, except that my CT scan in November turned out well and my next check-up is due in a week's time.

With this in mind, I wish us all a wonderful pre-Christmas period and a good end to the year...stay tuned 📈👋🏻

📈 Performance:

S&P500: -0.48%

MSCI World: -0.59%

DAX: -0.51%

Dividend portfolio: +2.91%

My high and low performers in November were (top/flop 3):

🟢 ($LLY (+3,19 %) ) Eli Lilly +24.74%

🟢 ($BATS (-2,66 %) ) British American Tobacco +13.36%

🟢 ($DHL (+0,05 %) ) Deutsche Post +12.64%

🔴 ($TSLA (+1,52 %) ) Tesla -6.57%

🔴 ($HD (+1,29 %) ) Home Depot -7.61%

🔴 ($LMT (+1,74 %) ) Lockheed Martin -16.76%

Dividends:

November 2025: €145.50 + €13.50 gross (Petroleo Brasileiro $PETR4 (+0,38 %) )

November 2024: € 129.78

Change: +12.11%

Sales:

🟥 None

Purchases:

🟩 ($ULVR (-0,71 %) ) Unilever (6 pcs.)

Savings plans:

($CTAS (-0,34 %) ) Cintas (50€)

($MC (-0,45 %) ) LVMH (50€)

($MSFT (-0,32 %) ) Microsoft (25€)

What else has happened?

November was also very quiet. Three weeks of vacation were planned, two of which are already over. I did a few things in and around the house, but otherwise did a lot of nothing and relaxed in preparation for Christmas.

🥅 Goals for 2025:

Deposit of €10,000 and thus a deposit volume in the share portfolio of ~€73,000

Target achievement at the end of November 2025: 82.35%

So I won't reach my personal target. However, a small consolation for me: I will achieve my own and rather unofficial target of € 2400 net dividend.

If you liked the report and would like to read more, feel free to follow me,

If you're not interested, you can keep scrolling or use the block function.

Jefferies sees upside potential for British American Tobacco p.l.c. $BATS (-2,66 %)after the company invited the management team to a conference last week.

Analyst Andrei Andon-Ionita said the firm has seen renewed confidence in the tobacco giant's volume growth in the oral nicotine pouch business as innovation potential may be unlocked in the US.

"The company believes that the volume of oral nicotine pouches in the US could almost double over the next three years, assuming per capita consumption remains stable. In addition, per capita consumption of US Velo (2-3 pouches/day) remains lower than in other markets (Sweden >12x/day, UK 5-6x/day), which we attribute to slower adoption of innovation compared to other markets," Andon-Ionita wrote.

The continued growth of the category will be supported by further innovation, as the success of Velo Plus in 2025 has already shown.

Jefferies is also cautiously optimistic about the enforcement of the ban on illegal e-cigarettes in the US and the stabilization of the tobacco products business in the US.

British American Tobacco appears to be in the early stages of a successful transition to a portfolio focused on smoke-free products.

Everyone perceives risks individually. Everyone tries to independently assess the risk of a share or the current economic situation on the stock market.

In portfolio theory, risk is primarily measured using the standard deviation. In simple terms, this is the extent to which a share price moves. If this movement is correlated with the "market", this results in a beta. If this is < 1 bedeutet das, dass der Kurs einer Aktie geringer als der Markt schwankt. > 1, the result is a disproportionate fluctuation. The "market" is an elastic term. For example, an MSCI World, S&P 500 or the DAX can be used as a reference. The result is different betas depending on the index. However, I do not want to go into this topic any further at this point.

Why beta is not relevant for me

• Price fluctuations are not a problem in my current life situation (24 years old; student).
• Every share that grows faster than the market has a beta > 1. As my portfolio is set to grow, a high beta is desirable.

Diversification as a risk?

I often see portfolios with 30+ companies on Getquin. The aim behind this is to minimize risk. In my view, however, what gets lost in the process is the overview - or leisure time, because every share in the portfolio should be tracked and scrutinized.

I have therefore opted for a clearly structured portfolio. There are currently 11 companies (but the number is not set in stone). There are two reasons for this:

I want to know and follow each company in my portfolio well

The impact of a price increase should be significant

My strategy for less drawdown despite fewer shares

• Cover as many sectors as possible
• Consider regional sales distribution
• Know a company as well as possible

Why these companies?

• Heidelberg Materials $HEI (-1,13 %). Local monopolies with strong pricing power
• Medpace$MEDP (-1,42 %). Enabler of small research/pharma teams. Enables research outside of Big Pharma
• Hims and Hers$HIMS (-1,33 %). Generics seller with "cool brand". Enables better margins in the long term.
• MercadoLibre $MELI (-0,2 %). The Amazon and bank of Latin America. To benefit from the rise of emerging markets.
• Meta Platforms$META (-1,55 %). Monopoly in communication/social media.
• Prada$1913 (+1 %). One of the few luxury companies that is constantly growing (and not highly valued). More on this in my last post.
• BATS$BATS (-2,66 %). Non-cyclical business model. Bought at the time due to significant undervaluation. Now I hold the share to stabilize the portfolio somewhat.
• Sanlorenzo$SL (+0,59 %). Yacht manufacturer and thus part of the luxury sector, which I find attractive due to its high margin and low cyclicality.
• Solaria $SLR (+1,06 %). My conservative bet on rising energy demand through AI.
• Metaplanet $3350 (-3,3 %). Bitcoin gamble with play money.

My criteria for buying shares

Basically, I hardly set myself any limits when investing. I like to invest in shares that are rather unpopular at the time of purchase. The sector doesn't matter, although I prefer high-margin business models.

I like to buy cheap - high P/E ratios put me off (even if FOMO sometimes kicks in). I don't feel comfortable with it because of the potential drop.

Wow. Thank you for reading this!

Now that you know my strategy, I would really appreciate some stock tips tips, that could fit my strategy.

By the way, can you see the portfolio? Because it's my own post I can't check it👀

Good evening, Grüezi mitenand & Glück auf !

I've had my securities account with Swissquote for about 3 months now & I'd be interested to hear what you have to say.

First of all: I simply sold everything at TR in Germany & then made a fresh start here in Switzerland.

I started with 10x $VWRL (-0,98 %) as a foundation stone. Since then, I've been adding CHF 300 per month - but the plan is to increase this savings plan to at least CHF 500 per month at first & later to CHF 800 & CHF 1000. Then I looked at what else I would like to have in my portfolio (again).

The results are as follows:

8 x $AD (-0,86 %) Ahold Delhaize

6 x $BATS (-2,66 %) British American Tobacco

1 x $CRM (-0,16 %) Salesforce

10 x $EQNR (+1,16 %) Equinor

10 x $HTGC (-0,31 %) Hercules Capital

300 CHF $LISN (+0 %) Lindt & Sprüngli

7 x $MAIN (-0,4 %) Main Street Capital

1 x $MCD (+1,12 %) McDonalds

6 x $MDLZ (+0,94 %) Mondelez

6 x $NOVO B (-0,2 %) Novo Nordisk

5 x $O (+0,92 %) Realty Income

30 x $OBDC (-0,87 %) Blue Owl Capital

2 x $PEP (+0,29 %) PepsiCo

5 x $RIO (-1,04 %) Rio Tinto

10 x $SHEL (-1 %) Shell

1 x $V (+0,4 %) Visa

2 x $ZTS (+0 %) Zoetis

The thought here was / is: I like to invest in values that are boring & that I / humanity often see / use / stumble across in my / their daily lives.

I don't buy individual stocks for now, except possibly Zoetis, Main or Salesforce. So far, I have not found any attractive entry points for tech stocks in this portfolio.

One more thing: I don't want to sell everything & shift into the VWRL, and I also know that at 28 I COULD perhaps focus more on growth. The portfolio should be geared towards the long term & dividends motivate me enormously. Just like a beer at the end of the day. 🥸😋

On the side, I still have around CHF 2000 on a crypto exchange $BTC (-1,78 %) Bitcoin lying around.

And now thanks for your opinions. ☺️